Key result
In left breast cancer patients receiving postoperative radiotherapy, radiation doses to the left ventricle were higher in patients who developed new perfusion defects, with a significant difference at segment 3 (1.76 Gy vs 1.39 Gy, p=0.03).
Why the study?
Radiation dose to the heart during adjuvant breast radiotherapy increases cardiotoxicity risk, motivating more precise evaluation of cardiac subvolume doses and myocardial perfusion defects using the AHA 20-segment model.
Does adjuvant radiotherapy cause new myocardial perfusion defects in specific left ventricular subvolumes in left breast cancer patients?
Observational (n=61)
No
Does adjuvant radiotherapy cause new myocardial perfusion defects in specific left ventricular subvolumes in left breast cancer patients?
Absolute Event Rate: 1.76% vs 1.39%
p-value: p=0.03
Adjuvant radiotherapy for left breast cancer is associated with new myocardial perfusion defects at 12 months, which correlate with higher subvolume radiation doses to specific left ventricular segments.
Higher LV segment doses were associated with perfusion defects; leaves open whether segment-specific sparing improves cardiac outcomes in left breast radiotherapy.
Adjuvant breast radiotherapy could reduce the risk of local recurrence. However, the radiation dose received by the heart also increases the risk of cardiotoxicity and causes consequential heart diseases. This prospective study aimed to evaluate more precisely cardiac subvolume doses and corresponding myocardial perfusion defects according to the American Heart Association (AHA)'s 20-segment model for single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) interpretation for breast cancer after radiotherapy. The 61 female patients who underwent adjuvant radiotherapy following breast cancer surgery for left breast cancer were enrolled. SPECT MPI were performed before radiotherapy for baseline study, and 12 months after for follow-up. Enrolled patients were divided into two groups, new perfusion defect (NPD) and non new perfusion defect found (non-NPD) according to myocardial perfusion scale score. CT simulation data, radiation treatment planning, and SPECT MPI images were fused and registered. The left ventricle was divided into four rings, three territories, and 20 segments according to the AHA's 20-segment model of the LV. The doses between NPD and non-NPD groups were compared by the Mann-Whitney test. The patients were divided into two groups: NPD group (n = 28) and non-NPD group (n = 33). The mean heart dose was 3.14 Gy in the NPD group and 3.08 Gy in the non-NPD group. Mean LV doses were 4.84 Gy and 4.71 Gy, respectively. The radiation dose of the NPD group was higher than the non-NPD group in the 20 segments of LV. There was significant difference in segment 3 (p = 0.03). The study indicated that the radiation doses to 20 segments of LV in NPD were higher than those in non-NPD significantly at segment 3, and higher in other segments in general. In the bull's eye plot combining radiation dose and NPD area, we found that the new cardiac perfusion decline may exist even in the low radiation dose region.Trial registration: FEMH-IRB-101085-F. Registered 01/01/2013, https://clinicaltrials.gov/ct2/show/NCT01758419?cond=NCT01758419&draw=2&rank=1 .
No takes yet. Share an insight, caveat, or question.
Wang et al. (2023) conducted an observational in Left breast cancer (n=61). Postoperative radiotherapy vs. Patients without new perfusion defects (non-NPD) was evaluated on Radiation dose to segment 3 of the left ventricle (p=0.03). In left breast cancer patients receiving postoperative radiotherapy, radiation doses to the left ventricle were higher in patients who developed new perfusion defects, with a significant difference at segment 3 (1.76 Gy vs 1.39 Gy, p=0.03).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: